Tom Taulli

Tom Taulli

Expertise: Artificial intelligence, cloud computing, cybersecurity

Education: BA, Cal Poly Pomona; JD, Whittier Law School

Awards & Accomplishments: IRS Enrolled Agent; California insurance license

Tom Taulli is the author of various books. They include Artificial Intelligence Basics and the Robotic Process Automation Handbook. His upcoming book is called Generative AI: How ChatGPT and other AI Tools Will Revolutionize Business.

Besides his writing, Tom has authored courses for PluralSight, Apress and O’Reilly Publishing. And yes, they are about topics like AI and cloud computing.

Tom currently advises various early stage companies about AI. He also is an angel investor.

Before this, Tom founded tech companies like ExamWeb, WebIPO and Hypermart, which was sold to InfoSpace.

Recent Articles

Berkshire Hathaway Stock Still Looks Dicey

Berkshire Hathaway stock has been a laggard for some time. And while here is some value here, investors may still want to pass on this one.

Why a Recession May Not Matter Much for Oracle Stock

Oracle has taken a dive like many other stocks. But this could be presenting a value opportunity in ORCL stock. Here’s why.

Chesapeake Energy Stock Goes to DEFCON 1

Chesapeake was already in dire straights. But the recent implosion of crude oil has made things even worse. Here’s why investors need to stay away from CHK stock.

Why 3M Stock Is Still Not Cheap Enough

MMM stock has been in a downward trend since early 2018, and now shares are certainly at value levels. But, the timing still may not be good.

If You’re Still in, It’s Time to Pull the Plug on Nio Stock

Nio has certainly beaten the odds. That is, the company recently raised a major infusion of capital. But investors should still be cautious.

Everything You Need to Know About Health Savings Accounts

Health savings accounts (HSAs) can be kind of complicated. But it is worth understanding this vehicle. Here’s a look at the key information.

3 Reasons To Get Cautious On Beyond Meat Stock

Beyond Meat has been one of past year’s top IPOs. But investors should be cautious given the intense competition and a sky-high valuation.

Amarin Stock Looks Like a Heart-Healthy Buy on the Dip

Amarin stock has hit a wall, potentially because of generics litigation. But I think this has been an overreaction. Here’s a look at why.

Inovio Has Potential Beyond Its Speculative Coronavirus Vaccine

INO stock has had a nice rally lately, primarily driven by the coronavirus. But this company has other treatments that could move the needle.

What’s on Tap for Plug Power Earnings This Week?

Plug Power has been able to create a strong platform, and there's traction with customers. So, what should we expect for PLUG stock earnings?